Creative Biolabs is strengthening its lipid-based delivery portfolio with enhanced lipid nanoparticle (LNP) and liposome engineering capabilities designed to support the growing demand for RNA ...

Biopharmaceutical developers should introduce risk-based, phase-appropriate characterization strategies for quality control ...

Immuron Engages Pullan Consulting to Advance IMM-529 Partnering Strategy; Immuron is seeking a partner to support clinical development through regulatory approval and ...

Two innovative, forward-thinking organizations show how rebuilding patient trust is becoming the real breakthrough driving ...

VERAXA Biotech (NASDAQ: VRXA) announced the initiation of cell line development for its lead BiTAC(R) T-cell engager ...

Practicing ophthalmologists have an amazing legacy of catalyzing innovation to enhance our ability to retain, restore and ...

Aligos Therapeutics, Inc. (Nasdaq: ALGS), a clinical stage biopharmaceutical company focused on improving patient outcomes through best-in-class therapies for liver and viral diseases, today announced ...

Satellos Bioscience Inc. (NASDAQ: MSLE, TSX: MSCL) (“Satellos” or the “Company”), a clinical-stage biotechnology company ...

A product approach that merges human-centered design with clinical validation can transform healthcare experiences, as the ...

HHS Secretary Robert F. Kennedy Jr. wants to speed up clinical trials in the United States.“A recent study found that China ...

Formulation complexity, especially in small molecule drugs, has been getting more attention as capabilities continue to ...

Healthcare veteran Dr Douglas Williams discusses the impact of recent political upheaval in the US and the prospect of major ...